Samira Rahimirad is a PhD candidate in Experimental Surgery at McGill University. Her research focuses on uncovering novel and minimally invasive blood-based approaches to monitor prostate cancer progression to the lethal stage. By applying cutting-edge technologies in molecular biology and bioinformatics, she analyzes both primary tumours and circulating cell-free tumour DNAs in blood longitudinally collected from patients with aggressive prostate cancer.